Screening for founder mutations in BRCA1 and BRCA2 has been discussed as a cost-effective testing strategy in certain po...
...BRCA2, the present meta-analysis was addressed to determine whether adjuvant tamoxifen treatment for breast cancer is as...
...BRCA2 mutations were hypersensitive to the PARP inhibitors olaparib and velaparib, but all other cell lines expressing f...
...BRCA2. One of the most extensively studied candidates for breast and/or ovarian cancer susceptibility is BARD1. Although...
...BRCA2 mutations and polymorphisms. Genomic DNA was amplified using the Ion AmpliSeq BRCA1 and BRCA2 panel. The DNA Libra...
...BRCA2 (BRCA1/2) have a better prognosis than BRCA1/2 alteration non-carriers. However, patients with wild-type BRCA1/2 m...
...BRCA2 and MSH2 that are predicted to disrupt splicing, prematurely truncate the protein, or remove the start codon were ...
...BRCA2 mutations have been linked to melanoma in large breast and ovarian cancer families, though a statistically signifi...
...BRCA2 gene and thereby normalize protein levels, contribute to stem cell homeostasis, and/or affect hormone levels, migh...
...BRCA2-deficient Capan-1 cells and cooperate with gemcitabine to the killing of pancreatic cancer cells. In conclusion, n...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269